4.2 Article

β-catenin and Tcfs in mammary development and cancer

Journal

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Volume 8, Issue 2, Pages 145-158

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1023/A:1025944723047

Keywords

catenin; Lef; Tcf; cyclins; MUC; Wnt

Funding

  1. NIGMS NIH HHS [GM47429] Funding Source: Medline

Ask authors/readers for more resources

beta-Catenin regulates cell-cell adhesion and transduces signals from many pathways to regulate the transcriptional activities of Tcf/Lef DNA binding factors. Gene ablation and transgenic expression studies strongly support the concept that beta-catenin together with Lef/Tcf factors act as a switch to determine cell fate and promote cell survival and proliferation at several stages during mammary gland development. Mice expressing the negative regulator of Wnt/beta-catenin signaling (K14-Dkk) fail to form mammary buds, and those lacking Lef-1 show an early arrest in this process at stage E13.5. Stabilized DeltaN89beta-catenin initiates precocious alveologenesis- during pubertal development, and negative regulators of endogenous beta-catenin signaling suppress normal alveologenesis during pregnancy. Stabilized beta-catenin induces hyperplasia and mammary tumors in mice. Each of the beta-catenin-induced phenotypes is accompanied by upregulation of the target genes cyclin D1 and c-myc. Cyclin D1, however, is dispensable for tumor formation and the initiation of alveologenesis but is essential for later alveolar expansion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available